Literature DB >> 3169952

Nifedipine: individual responses and concentration-effect relationships.

R Donnelly1, H L Elliott, P A Meredith, A W Kelman, J L Reid.   

Abstract

Dynamic and kinetic variability account for the large intersubject differences in the antihypertensive response to nifedipine, and a clear concentration-effect relationship has not been established. The effects of placebo, first dose, and chronic (1 and 6 weeks) treatment with nifedipine were studied in 14 subjects with essential hypertension using an integrated kinetic-dynamic model to calculate individual subject responsiveness in terms of fall in blood pressure per unit change in drug concentration. Nifedipine concentrations were well correlated with the fall in systolic blood pressure in individual subjects, and the mean responsiveness was -0.48 mm Hg/ng/ml after the first dose, -0.45 mm Hg/ng/ml after 1 week, and -0.49 mm Hg/ng/ml after 6 weeks. The responsiveness to the first dose of nifedipine was significantly correlated with the responsiveness after 1 (r = 0.83) and 6 weeks (r = 0.78) of therapy and with the height of the pretreatment blood pressure (r = 0.6). This study incorporated kinetic as well as dynamic information to characterize the antihypertensive response to nifedipine and identify nifedipine concentration-effect relationships in individual hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169952     DOI: 10.1161/01.hyp.12.4.443

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

Review 1.  Selecting the right drug for initial antihypertensive therapy.

Authors:  A B Weder
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

2.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

3.  Pharmacokinetic-pharmacodynamic model for fantofarone cardiac and brachial haemodynamic effects in healthy volunteers.

Authors:  E Bellissant; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

4.  The description and prediction of antihypertensive drug response: an individualised approach.

Authors:  R Donnelly; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

Review 5.  The implications of noncompliance with antihypertensive medication.

Authors:  B Girvin; G D Johnston
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

6.  Encounter frequency and serum glucose level, blood pressure, and cholesterol level control in patients with diabetes mellitus.

Authors:  Fritha Morrison; Maria Shubina; Alexander Turchin
Journal:  Arch Intern Med       Date:  2011-09-26

Review 7.  Pharmacokinetic-pharmacodynamic relationships of alpha-adrenoceptor antagonists.

Authors:  R Donnelly; P A Meredith; H L Elliott
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

8.  The effects of age on the pharmacokinetics, antihypertensive efficacy and general tolerability of dilevalol.

Authors:  G J Macphee; C A Howie; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 9.  The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.

Authors:  J S Grundy; R T Foster
Journal:  Clin Pharmacokinet       Date:  1996-01       Impact factor: 6.447

10.  Formulation of long-acting nifedipine tablets influences the heart rate and sympathetic nervous system response in hypertensive patients.

Authors:  Morris J Brown; Corey B Toal
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.